Results 141 to 150 of about 14,040 (225)

Statins and Fibrates in Age-Related Macular Degeneration: A Contemporary Clinical Narrative Review (2020-2025). [PDF]

J Clin Med
Dmoch W, Sawicka J, Żelichowska N, Kępczyńska Z, Maciejewicz P, Kęcik D.   +5 more
europepmc   +1 more source

Effects of fenofibrate on angiopoietin-like 3/4/8 proteins and apolipoprotein A5. [PDF]

J Lipid Res
Yang Y, Smith S, Chen YQ, Li H, Zhen EY, Sloan JH, Siegel RW, Qian Y, Wen Y, Jung H, Scheithauer JL, Kersten S, Young SG, Konrad RJ.   +13 more
europepmc   +1 more source

Novel Approaches to Lipid Management: Beyond Statins and PCSK9 Inhibitors. [PDF]

J Clin Med Res
Patel J, Shah S, Reddy A, Prajapati D, Pandya A, Sawhney S.   +5 more
europepmc   +1 more source

TLR4-Mediated Immune Dysfunction Links MASLD and Parkinson's Disease: Insights from an Omics-Based Network Analysis. [PDF]

NeuroSci
Flourou C, Dietis N, Tsiordas S, Hadjigeorgiou G, Vavougios GD.   +4 more
europepmc   +1 more source

Design of the Japan Kidney Association-Pemafibrate Intervention for Chronic Kidney Disease patients Study (JKAPI-CKD Study). [PDF]

Clin Kidney J
Kinguchi S, Tamura K, Yano Y, Nangaku M, Isaka Y, Maruyama S, Kanegae H, Heerspink HL, Nakagawa N, Nishio S, Asahi K, Yamagata K, Fukui A, Okada H, Narita I, Tsuruya K, Wada J, Terada Y, Mukoyama M, Imai E, Yokota N, Kobayashi K, Kashihara N.   +22 more
europepmc   +1 more source

Cholestatic and autoimmune liver diseases, bile duct injury, oxidative stress, and therapeutic strategies. [PDF]

Front Physiol
Stygar D, Bogielski B, Michalczyk K, Skrzep-Poloczek B, Suchocka A, Nikiel K, Kukla K, Wasek R, Staniszewski J, Matyja M, Kukla M.   +10 more
europepmc   +1 more source

Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectives. [PDF]

Front Pharmacol
Tamehri Zadeh SS, Toth PP, Banach M.
europepmc   +1 more source

Navigating hypertriglyceridemia in pregnancy: current evidence and clinical strategies. [PDF]

Front Endocrinol (Lausanne)
Chamerski S, Wartecka-Zielińska K, Pomorski F, Karos W, Marlęga-Linert J, Marcinkowska M, Stefańska K, Grzybowska M, Wydra D, Gruchała M, Mickiewicz A.   +10 more
europepmc   +1 more source

Are lipid-lowering therapies used according to the guidelines?: A real-world retrospective study of 1001 patients with type 2 diabetes. [PDF]

Medicine (Baltimore)
Şahin MF, Erol A, Bayrak G, Şahin A.
europepmc   +1 more source

Importance and Management of Non-High-Density Lipoprotein Cholesterol in Dyslipidemia Treatment. [PDF]

JACC Asia
O'Brien RC, Gonzalez-Santos LE, Tomlinson B, Hussein Z, Lim S, Nawawi H, Ong HY, Silki S, Soegondo S, Su TC, Sukonthasarn A, Vinh PN.   +11 more
europepmc   +1 more source